Artal Group’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-303,369
Closed -$43.3M 105
2024
Q2
$43.3M Sell
303,369
-101,413
-25% -$15.6M 1.1% 13
2024
Q1
$63.3M Buy
404,782
+302
+0.1% +$48.6K 1.61% 10
2023
Q4
$73M Buy
404,480
+546
+0.1% +$98.8K 2.43% 6
2023
Q3
$72.7M Sell
403,934
-8,562
-2% -$1.69M 3.12% 4
2023
Q2
$73.5M Sell
412,496
-88,839
-18% -$20.5M 2.28% 7
2023
Q1
$108M Sell
501,335
-98,665
-16% -$23.7M 6.42% 2
2022
Q4
$132M Sell
600,000
-50,000
-8% -$9.17M 7.37% 2
2022
Q3
$87.6M Hold
650,000
3.74% 4
2022
Q2
$105M Sell
650,000
-15,000
-2% -$2.34M 5.62% 3
2022
Q1
$125M Sell
665,000
-10,000
-1% -$2.13M 5.25% 4
2021
Q4
$183M Buy
675,000
+25,000
+4% +$8.44M 4.96% 4
2021
Q3
$236M Sell
650,000
-200,000
-24% -$65.4M 5.28% 3
2021
Q2
$292M Hold
850,000
5.92% 3
2021
Q1
$296M Sell
850,000
-150,000
-15% -$49.7M 5.23% 3
2020
Q4
$258M Buy
1,000,000
+100,000
+11% +$27.5M 5.55% 3
2020
Q3
$258M Buy
900,000
+50,000
+6% +$11.8M 6.26% 3
2020
Q2
$160M Buy
850,000
+200,000
+31% +$32.6M 4.48% 3
2020
Q1
$80M Buy
650,000
+10,000
+2% +$1.56M 3.38% 7
2019
Q4
$106M Sell
640,000
-10,000
-2% -$1.66M 4.1% 4
2019
Q3
$79.6M Hold
650,000
3.19% 6
2019
Q2
$80.6M Buy
650,000
+50,000
+8% +$6.35M 3.26% 5
2019
Q1
$79.2M Hold
600,000
3.23% 4
2018
Q4
$84.2M Hold
600,000
3.12% 5
2018
Q3
$103M Sell
600,000
-75,000
-11% -$12.6M 2.69% 5
2018
Q2
$104M Buy
675,000
+75,000
+13% +$13.4M 2.21% 5
2018
Q1
$101M Buy
600,000
+300,000
+100% +$40.6M 1.26% 7
2017
Q4
$29.3M Buy
300,000
+75,000
+33% +$6.87M 0.44% 20
2017
Q3
$23.3M Sell
225,000
-175,000
-44% -$13M 0.4% 17
2017
Q2
$18M Buy
400,000
+36,714
+10% +$1.45M 0.31% 27
2017
Q1
$13.3M Buy
363,286
+63,286
+21% +$2.31M 0.3% 30
2016
Q4
$9.11M Buy
+300,000
New +$9.43M 0.2% 38

Other funds holding ONC